StockData
BridgeBio Oncology Therapeutics, Inc. logo

BridgeBio Oncology Therapeutics, Inc. (BBOT) income statement

BBOTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.86+0.06 (+3.05%)

Close on Nov 19, 2026Market cap $149.12MP/E –Yield –

BridgeBio Oncology Therapeutics, Inc. financial ratios

See a number that looks wrong?